Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Reviews and Research in Medical Microbiology ; 34(1):51-60, 2023.
Article in English | GIM | ID: covidwho-2265237

ABSTRACT

Introduction: Coronavirus disease 2019 (COVID-19) pandemic is posing challenge to the public health sector. The present study assessed knowledge, attitude, and practice (KAP) towards this COVID-19 among Indian population. Methods: The online cross-sectional survey for evaluating KAP towards COVID-19 was conducted (n = 2059) among Indian residents. Choropleth maps analysis was carried out to present the state-wise distribution, and Moran's I tool to assess KAP's overall spatial autocorrelation. Results: Our results demonstrated an average KAP score of 16.9 +or- 2.0 (1.0, 22.0), 9.5 +or- 2.0 (0.0, 12.0) and 4.0 +or- (4.0, 4.0) (0.0, 5.0). The Moran's I tool for KAP's spatial autocorrelations observed as low as -0.04, -0.06, and 0.004. Conclusion: The interventional programs have to be encouraged for disease spread, and improving the public's practice for a better quality of life. Adherence to precautionary measures as per the standard guidelines is essential to prevent the spread of the disease, which might be subjective to the general population's knowledge and attitudes towards COVID-19.

2.
1st International Conference on Technologies for Smart Green Connected Society 2021, ICTSGS 2021 ; 107:1409-1419, 2022.
Article in English | Scopus | ID: covidwho-1874752

ABSTRACT

The treatment of patients having Myasthenia gravis and COVID-19 is a new domain for scientific research wherein a standard model is yet to be firmly established due to the dynamic nature of the development of the two diseases in the patients. Based on a few reports obtained, one study involved the application of Dexamethasone and Remdesivir in a measured dosage. The main drug of interest for this study was Dexamethasone because of its innate nature of acting as an immunosuppressive agent which helps combating the cytokine storms which is known to cause severe respiratory issues in COVID-19 affected patients. This drug, however, does not tackle the root problem. To target the virus, Remdesivir is chosen. The results seen are in agreement with our observations which indicate that for the overall improvement in patient health to be seen a combination of the both these drugs along with other support systems need to be taken in order to ensure overall improvement in patient recovery.Based on the observed binding affinities, improved drugs can be made. © The Electrochemical Society

SELECTION OF CITATIONS
SEARCH DETAIL